1937. Use of Paxlovid for Treatment of Acute COVID-19 and Occurrence of Post-COVID Conditions among Children and Adults at High-Risk for Severe COVID-19, April 1 - December 31, 2022

BACKGROUND: Data have suggested that treatment with Paxlovid for acute COVID-19 decreases the incidence of Post-COVID Conditions (PCC); however, results are limited to specific age groups and populations. This analysis assessed the occurrence of PCC following receipt of Paxlovid among children and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalton, Alexandra F, Baca, Sarah, Raykin, Julia, Perrine, Cria, Boehmer, Tegan, Koumans, Emilia, Patel, Priti, Saydah, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677759/
http://dx.doi.org/10.1093/ofid/ofad500.2468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677759/
http://dx.doi.org/10.1093/ofid/ofad500.2468

Ejemplares similares